Overview

Variant ID 28169
Entrez Gene ID 2903
Gene GRIN2A (GeneCards)
Location hg19 16:10316934-10316934
hg38 16:10223077-10223077
Disease Asymptomatic
Method Single cell Sequencing Cell cloning
Mutation(HGVS format) NC_000016.9:g.10316934 A>G (Genome Assembly: GRCh37)

Other information

Exon or Intron NA
Position in protein NA
Amino acid changes in protein NA > NA
Position in cDNA NA
Changes in cDNA NA > NA
mRNA accession NA
mRNA length NA
Reference length 90354753

Annotations and predictions

MAF in gnomAD genome (version 2.0.1) 0
EIGEN score -0.1545
CADD Raw score (version 1.3) -0.04835 (Deleterious)
FATHMM raw prediction score 0.1358 (Tolerated)
Deleterious probability by DeFine 0.5026 (Deleterious)
Entrez Gene ID 2903 (NCBI Gene)
Official Gene Symbol GRIN2A (GeneCards)
Number of variants in GRIN2A in this database 66 (view all the variants)
Full name glutamate ionotropic receptor NMDA type subunit 2A
Band 16p13.2
Other IDs Vega: OTTHUMG00000129721
OMIM: 138253
HGNC: HGNC:4585
Ensembl: ENSG00000183454
Other names LKS, EPND, FESD, NR2A, GlN2A, NMDAR2A
Summary This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Individual #1

Individual ID 29217587.02 (view all the variants in this individual)
Pubmed ID 29217587
Whose mosaic mutation Normal  
Phenotype 1  
Disease Asymptomatic
OMIM ID